Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
2,043,173
-
Number of holders
-
0
-
Total 13F shares, excl. options
-
0
-
Shares change
-
-135,389
-
Total reported value, excl. options
-
$0
-
Value change
-
-$599,932
-
Number of sells
-
-14
Significant Holders of NeuroMetrix, Inc. - Common Stock, $0.0001 par value per share (NURO) as of Q2 2025
14 filings reported holding NURO - NeuroMetrix, Inc. - Common Stock, $0.0001 par value per share as of Q2 2025.
NeuroMetrix, Inc. - Common Stock, $0.0001 par value per share (NURO) has 0 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 0 shares
of 2,043,173 outstanding shares and own 0% of the company stock.
Largest 10 shareholders include DELTEC ASSET MANAGEMENT LLC (0 shares), HARBOUR INVESTMENTS, INC. (0 shares), Accent Capital Management, LLC (0 shares), GEODE CAPITAL MANAGEMENT, LLC (0 shares), GTS SECURITIES LLC (0 shares), VANGUARD GROUP INC (0 shares), BlackRock, Inc. (0 shares), RENAISSANCE TECHNOLOGIES LLC (0 shares), UBS Group AG (0 shares), and Mariner, LLC (0 shares).
This table shows the top 0 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.